Precision BioSciences
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 20061, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1229740995 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Precision BioSciences” date of foundation (×1) · confidence 0.95 revision URL